TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

NCT04760431 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Brain Metastases

Interventions

DRUG: Trastuzumab
DRUG: Taxanes
DRUG: Pertuzumab
DRUG: Tyrosine kinase inhibitor

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]